Speaker illustration

Doctor Huihua Li

Pfizer Inc., New York (United States of America)

Estimating treatment effect of tafamidis on hospitalisation in NYHA class III ATTR-CM patients in the presence of death using principal stratification

Event: ESC Congress 2021 - The Digital Experience

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic heart failure e-posters

Thumbnail